Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis

被引：0
|
作者：
Spessotto, Caroline [1 ]
Cavalli, Hanaie [2 ]
Eboni, Audred [3 ]
Machado, Rafael [4 ]
Mousquer, Analara [5 ]
Palazzo, Lara [4 ]
Finkelsztejn, Alessandro [4 ]
Goncalves, Marcos [3 ]
Sato, Henry [2 ]
Siquineli, Fabio [5 ]
Fragoso, Yara [2 ]
机构：
[1] Univ Metropolitana Santos, Sao Paulo, Brazil
[2] Inst Neurol Curitiba, Curitiba, Parana, Brazil
[3] Ctr Hosp Unimed Joinville, Joinville, Brazil
[4] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[5] Univ Reg Blumenau, Blumenau, Brazil
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
57
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
    Spessotto, Caroline Vieira
    Cavalli, Hanaie
    Biondo Eboni, Audred Cristina
    Machado, Rafael Berlezi
    Mousquer, Analara Munardi
    Palazzo, Lara Both
    Finkelsztejn, Alessandro
    Magno Goncalves, Marcus Vinicius
    Sato, Henry Koiti
    Siquineli, Fable
    Fragoso, Yara Dadalti
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (08) : 617 - 620
  • [2] FIRST USE OF DISEASE-MODIFYING DRUGS IN PATIENTS WITH MULTIPLE SCLEROSIS
    Meletiche, D. M.
    Kozma, C.
    Dickson, M.
    VALUE IN HEALTH, 2009, 12 (03) : A193 - A193
  • [3] Vaccinations in multiple sclerosis patients receiving disease-modifying drugs
    Otero-Romero, Susana
    Ascherio, Alberto
    Lebrun-Frenay, Christine
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (03) : 322 - 328
  • [4] Use of Disease-Modifying Drugs in Multiple Sclerosis
    Wurzius, F. Q.
    Silva, C. B.
    de Vecino, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 102 - 103
  • [5] Time to First Treatment with Disease-Modifying Drugs in Newly Diagnosed Patients with Multiple Sclerosis
    Meletiche, Dennis M.
    Kozma, Chris
    Dickson, Michael
    NEUROLOGY, 2009, 72 (11) : A315 - A315
  • [6] Disease-Modifying Therapy in Multiple Sclerosis: Evaluation of Patients Satisfaction in Iranian Multiple Sclerosis Population
    Molazadeh, Negar
    Sahraian, Mohammad Ali
    Ghajarzadeh, Mahsa
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (01) : 89 - 93
  • [7] Predictors of relapses in patients with multiple sclerosis treated with disease-modifying drugs
    Steinman, L.
    Obi-Tabot, E.
    Wang, H.
    Guilhaume, C.
    Sondhi, M.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S413 - S413
  • [8] Monitoring the use of disease-modifying drugs in multiple sclerosis
    Poluzzi, Elisabetta
    Piccinni, Carlo
    Sacripanti, Chiara
    Tola, Maria Rosaria
    D'Alessandro, Roberto
    Montanaro, Nicola
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S33 - S34
  • [9] Postmarketing evidence of disease-modifying drugs in multiple sclerosis
    Trojano, Maria
    Paolicelli, Damiano
    Fuiani, Aurora
    Pellegrini, Fabio
    Iaffaldano, Pietro
    Direnzo, Vita
    D'Onghia, Mariangela
    NEUROLOGICAL SCIENCES, 2008, 29 (Suppl 2) : S225 - S226
  • [10] The Disability Outcomes of Disease-Modifying Drugs in Multiple Sclerosis
    Hader, Walter
    NEUROLOGY, 2012, 78
12345